269 related articles for article (PubMed ID: 26209654)
1. Local axonal protection by WldS as revealed by conditional regulation of protein stability.
Wang JT; Medress ZA; Vargas ME; Barres BA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10093-100. PubMed ID: 26209654
[TBL] [Abstract][Full Text] [Related]
2. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
3. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.
Beirowski B; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
BMC Neurosci; 2005 Feb; 6():6. PubMed ID: 15686598
[TBL] [Abstract][Full Text] [Related]
4. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
5. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy.
Wang MS; Fang G; Culver DG; Davis AA; Rich MM; Glass JD
Ann Neurol; 2001 Dec; 50(6):773-9. PubMed ID: 11761475
[TBL] [Abstract][Full Text] [Related]
6. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning.
Hoopfer ED; McLaughlin T; Watts RJ; Schuldiner O; O'Leary DD; Luo L
Neuron; 2006 Jun; 50(6):883-95. PubMed ID: 16772170
[TBL] [Abstract][Full Text] [Related]
7. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
Simonin Y; Perrin FE; Kato AC
J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
[TBL] [Abstract][Full Text] [Related]
8. Demyelination can proceed independently of axonal degradation during Wallerian degeneration in wlds mice.
Takada H; Yuasa S; Araki T
Eur J Neurosci; 2011 Aug; 34(4):531-7. PubMed ID: 21749497
[TBL] [Abstract][Full Text] [Related]
9. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in the initiation phase of Wallerian degeneration.
Chang B; Quan Q; Lu S; Wang Y; Peng J
Eur J Neurosci; 2016 Aug; 44(4):2040-8. PubMed ID: 27062141
[TBL] [Abstract][Full Text] [Related]
12. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.
Antenor-Dorsey JA; O'Malley KL
Mol Neurodegener; 2012 Feb; 7():5. PubMed ID: 22315973
[TBL] [Abstract][Full Text] [Related]
13. NAD and axon degeneration: from the Wlds gene to neurochemistry.
Wang J; He Z
Cell Adh Migr; 2009; 3(1):77-87. PubMed ID: 19372760
[TBL] [Abstract][Full Text] [Related]
14. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Araki T; Sasaki Y; Milbrandt J
Science; 2004 Aug; 305(5686):1010-3. PubMed ID: 15310905
[TBL] [Abstract][Full Text] [Related]
15. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
Mack TG; Reiner M; Beirowski B; Mi W; Emanuelli M; Wagner D; Thomson D; Gillingwater T; Court F; Conforti L; Fernando FS; Tarlton A; Andressen C; Addicks K; Magni G; Ribchester RR; Perry VH; Coleman MP
Nat Neurosci; 2001 Dec; 4(12):1199-206. PubMed ID: 11770485
[TBL] [Abstract][Full Text] [Related]
16. Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.
Watanabe M; Tsukiyama T; Hatakeyama S
Neurosci Lett; 2007 Jan; 411(3):228-32. PubMed ID: 17113230
[TBL] [Abstract][Full Text] [Related]
17. Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).
Wishart TM; Pemberton HN; James SR; McCabe CJ; Gillingwater TH
Genome Biol; 2008; 9(6):R101. PubMed ID: 18570652
[TBL] [Abstract][Full Text] [Related]
18. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.
Beirowski B; Babetto E; Coleman MP; Martin KR
Eur J Neurosci; 2008 Sep; 28(6):1166-79. PubMed ID: 18783366
[TBL] [Abstract][Full Text] [Related]
19. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
[TBL] [Abstract][Full Text] [Related]
20. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]